Not applicableLooking for participantsNCT06648057
What this trial is testing
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
Who this might be right for
Biliary Tract CancerCholangiocarcinoma
CHA University 100